TAKEDA PHARMACEUTICAL CO LTD

Related Filers (44)

Other (288)

6-K
Friday, 2/9/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/2/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/1/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/1/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/16/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 12/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 10/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 10/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 10/18/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 10/18/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/2/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/28/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 9/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/12/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Monday, 7/10/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 7/10/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 7/10/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 7/10/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 7/10/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 7/10/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 7/10/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 7/10/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 7/10/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 7/10/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 7/10/2023
Filing for proposed sale of securities under Rule 144
6-K
Thursday, 7/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/28/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Wednesday, 6/28/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Wednesday, 6/28/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/17/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
SD
Monday, 5/15/2023
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
6-K
Thursday, 5/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 3/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 3/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 3/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 3/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/10/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 2/7/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/2/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/10/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 1/5/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/21/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/13/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 12/8/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/30/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 10/27/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 10/14/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 10/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/23/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/11/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 7/5/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Wednesday, 6/29/2022
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Wednesday, 6/29/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/29/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/29/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/24/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/10/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/31/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/31/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/31/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/31/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/31/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
SD
Friday, 5/13/2022
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
6-K
Thursday, 5/12/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/11/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/11/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 4/19/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/14/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/13/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 4/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 4/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/22/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 3/14/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 2/14/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/10/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/3/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/3/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/3/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 1/13/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Show More

Ownership (102)

SC 13G/A
Tuesday, 2/6/2024
BlackRock Inc.: Major Shareholders
SC 13G/A
Monday, 2/5/2024
Sumitomo Mitsui Trust Holdings, Inc.: Major Shareholders
SC 13D/A
Thursday, 1/25/2024
Phathom Pharmaceuticals, Inc.: Major Shareholders
4
Thursday, 1/25/2024
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 1/19/2024
Equillium, Inc.: Major Shareholders
SC 13D/A
Friday, 5/26/2023
Calithera Biosciences, Inc.: Major Shareholders
4
Friday, 5/26/2023
Calithera Biosciences, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/7/2023
BlackRock Inc.: Major Shareholders
SC 13G/A
Friday, 2/3/2023
Day One Biopharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Friday, 2/3/2023
Sumitomo Mitsui Trust Holdings, Inc.: Major Shareholders
SC 13G/A
Friday, 2/3/2023
Ovid Therapeutics Inc.: Major Shareholders
SC 13G/A
Friday, 2/3/2023
Ovid Therapeutics Inc.: Major Shareholders
4
Thursday, 12/1/2022
HilleVax, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 8/5/2022
BiomX Inc.: Major Shareholders
4
Wednesday, 7/6/2022
Ovid Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/6/2022
Calithera Biosciences, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 7/6/2022
Calithera Biosciences, Inc.: Major Shareholders
3/A
Monday, 5/9/2022
HilleVax, Inc.: Initial statement of beneficial ownership of securities
SC 13D
Monday, 5/9/2022
HilleVax, Inc.: Major Shareholders
3
Friday, 4/29/2022
HilleVax, Inc.: Initial statement of beneficial ownership of securities
SC 13D
Thursday, 4/21/2022
Calithera Biosciences, Inc.: Major Shareholders
3
Thursday, 4/21/2022
Calithera Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 3/16/2022
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 2/4/2022
Sumitomo Mitsui Trust Holdings, Inc.: Major Shareholders
SC 13G/A
Thursday, 2/3/2022
BlackRock Inc.: Major Shareholders
SC 13G
Friday, 1/14/2022
Day One Biopharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Friday, 1/14/2022
Shattuck Labs, Inc.: Major Shareholders
SC 13G
Friday, 1/14/2022
Xilio Therapeutics, Inc.: Major Shareholders
4
Thursday, 12/9/2021
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/7/2021
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/29/2021
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 11/12/2021
Phathom Pharmaceuticals, Inc.: Major Shareholders
4
Monday, 11/8/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/26/2021
Xilio Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 10/25/2021
Mirum Pharmaceuticals, Inc.: Major Shareholders
3
Thursday, 10/21/2021
Xilio Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Monday, 10/18/2021
BiomX Inc.: Major Shareholders
4
Friday, 10/15/2021
Theseus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 10/15/2021
Theseus Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Tuesday, 9/14/2021
Molecular Templates, Inc.: Major Shareholders
SC 13G/A
Monday, 8/30/2021
HOOKIPA Pharma Inc.: Major Shareholders
4
Friday, 7/9/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/6/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/29/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/25/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/23/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/21/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/16/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/11/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/9/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/4/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/2/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/28/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/26/2021
Day One Biopharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 5/26/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/24/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/18/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/14/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/11/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/7/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/5/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 4/6/2021
Phathom Pharmaceuticals, Inc.: Major Shareholders
SC 13D/A
Thursday, 4/1/2021
Phathom Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Friday, 2/5/2021
Sumitomo Mitsui Trust Holdings, Inc.: Major Shareholders
SC 13G/A
Monday, 2/1/2021
BlackRock Inc.: Major Shareholders
SC 13G/A
Friday, 1/29/2021
Cortexyme, Inc.: Major Shareholders
SC 13G/A
Friday, 1/29/2021
Shattuck Labs, Inc.: Major Shareholders
SC 13G/A
Wednesday, 1/27/2021
Mirum Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Monday, 1/25/2021
Translate Bio, Inc.: Major Shareholders
4
Tuesday, 6/30/2020
Translate Bio, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/5/2020
Translate Bio, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/3/2020
Translate Bio, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/3/2020
Translate Bio, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Friday, 2/14/2020
CAUSEWAY CAPITAL MANAGEMENT LLC: Major Shareholders
SC 13G/A
Thursday, 2/6/2020
BlackRock Inc.: Major Shareholders
SC 13D/A
Monday, 1/27/2020
Phathom Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Friday, 1/24/2020
Myovant Sciences Ltd.: Major Shareholders
SC 13G/A
Friday, 1/24/2020
Myovant Sciences Ltd.: Major Shareholders
4
Friday, 11/22/2019
Ovid Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 11/22/2019
Ovid Therapeutics Inc.: Major Shareholders
SC 13G/A
Friday, 11/22/2019
Ovid Therapeutics Inc.: Major Shareholders
3
Friday, 11/22/2019
Ovid Therapeutics Inc.: Initial statement of beneficial ownership of securities
SC 13D
Wednesday, 11/6/2019
Phathom Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Wednesday, 11/6/2019
BiomX Inc.: Major Shareholders
3
Tuesday, 11/5/2019
BiomX Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 10/24/2019
Phathom Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Tuesday, 9/10/2019
Mirum Pharmaceuticals, Inc.: Major Shareholders
3
Wednesday, 7/17/2019
Mirum Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Monday, 5/20/2019
Cortexyme, Inc.: Major Shareholders
4
Monday, 5/13/2019
Cortexyme, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/8/2019
Cortexyme, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Friday, 4/26/2019
HOOKIPA Pharma Inc.: Major Shareholders
SC 13G
Thursday, 2/14/2019
Translate Bio, Inc.: Major Shareholders
SC 13G
Thursday, 2/14/2019
CAUSEWAY CAPITAL MANAGEMENT LLC: Major Shareholders
SC 13G
Friday, 2/8/2019
BlackRock Inc.: Major Shareholders
SC 13G
Monday, 4/16/2018
Ovid Therapeutics Inc.: Major Shareholders
4
Wednesday, 3/21/2018
Myovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
SC 13D
Friday, 1/12/2018
TiGenix NV: Major Shareholders
3
Friday, 9/8/2017
Molecular Templates, Inc.: Initial statement of beneficial ownership of securities
SC 13D
Thursday, 8/10/2017
Molecular Templates, Inc.: Major Shareholders
Show More

Prospectus (41)

S-8
Wednesday, 6/28/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Wednesday, 6/29/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Thursday, 10/28/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B2
Tuesday, 6/30/2020
Prospectus filed pursuant to Rule 424(b)(2)
FWP
Tuesday, 6/30/2020
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B2
Tuesday, 6/30/2020
Prospectus filed pursuant to Rule 424(b)(2)
FWP
Tuesday, 6/30/2020
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B5
Thursday, 6/25/2020
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Thursday, 6/25/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Thursday, 6/25/2020
Prospectus filed pursuant to Rule 424(b)(5)
424B3
Thursday, 11/14/2019
Prospectus filed pursuant to Rule 424(b)(3)
DRS/A
Friday, 11/16/2018
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Friday, 11/16/2018
Correspondence Related to Draft Registration Statement
DRS
Tuesday, 9/11/2018
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
SC TO-T/A
Tuesday, 7/31/2018
Third party tender offer statement
SC TO-T/A
Thursday, 7/26/2018
Third party tender offer statement
SC TO-T/A
Friday, 7/6/2018
Third party tender offer statement
SC TO-T/A
Tuesday, 7/3/2018
Third party tender offer statement
SC TO-T/A
Wednesday, 6/6/2018
Third party tender offer statement
SC TO-T/A
Thursday, 5/31/2018
Third party tender offer statement
SC TO-T/A
Wednesday, 5/23/2018
Third party tender offer statement
SC TO-T/A
Friday, 5/18/2018
Third party tender offer statement
SC TO-T/A
Friday, 5/11/2018
Third party tender offer statement
SC TO-T
Monday, 4/30/2018
Third party tender offer statement
SC TO-C
Wednesday, 4/25/2018
Written communication relating to an issuer or third party tender offer
SC TO-C
Friday, 3/23/2018
Written communication relating to an issuer or third party tender offer
SC TO-C
Tuesday, 2/13/2018
Written communication relating to an issuer or third party tender offer
SC TO-C
Thursday, 2/1/2018
Written communication relating to an issuer or third party tender offer
SC TO-C
Friday, 1/26/2018
Written communication relating to an issuer or third party tender offer
SC TO-C
Tuesday, 1/9/2018
Written communication relating to an issuer or third party tender offer
SC TO-C
Friday, 1/5/2018
Written communication relating to an issuer or third party tender offer
SC TO-C
Friday, 1/5/2018
Written communication relating to an issuer or third party tender offer
SC TO-T/A
Thursday, 2/16/2017
Third party tender offer statement
SC TO-T/A
Wednesday, 2/8/2017
Third party tender offer statement
SC TO-T/A
Thursday, 2/2/2017
Third party tender offer statement
SC TO-T/A
Monday, 1/30/2017
Third party tender offer statement
SC TO-T/A
Tuesday, 1/24/2017
Third party tender offer statement
SC TO-T
Thursday, 1/19/2017
Third party tender offer statement
SC TO-C
Wednesday, 1/11/2017
Written communication relating to an issuer or third party tender offer
SC TO-C
Tuesday, 1/10/2017
Written communication relating to an issuer or third party tender offer
SC TO-C
Monday, 1/9/2017
Written communication relating to an issuer or third party tender offer
Show More